(Q33779880)

29 July 2017

1 reference

title

Is valproate pharmacotherapy associated with polycystic ovaries? (English)

1 reference

29 July 2017

0 references

K A Chappell

1

1 reference

29 July 2017

J S Markowitz

series ordinal

2

1 reference

29 July 2017

C W Jackson

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Annals of Pharmacotherapy

29 July 2017

1 reference

29 July 2017

33

1 reference

29 July 2017

1211-1216

1 reference

29 July 2017

11

1 reference

Mechanism of anticonvulsant action of valproate

29 July 2017

1 reference

Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

21 January 2018

1 reference

Role of cytochrome P450c17 in polycystic ovary syndrome

21 January 2018

1 reference

The polycystic ovary syndrome

21 January 2018

1 reference

Obesity and endocrine disorders in women taking valproate for epilepsy.

21 January 2018

1 reference

Polycystic ovaries--a common finding in normal women

21 January 2018

1 reference

Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs

21 January 2018

1 reference

Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy.

21 January 2018

1 reference

The effects of sodium valproate on plasma somatostatin and insulin in humans.

21 January 2018

1 reference

Maximizing the health of women with epilepsy: science and ethics in new drug development

21 January 2018

1 reference

UDP-glucuronosyltransferases: a family of detoxifying enzymes

21 January 2018

1 reference

The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence

21 January 2018

1 reference

Sodium valproate acutely inhibits lamotrigine metabolism

21 January 2018

1 reference

Inhibition of human and rabbit liver steroid and xenobiotic UDP-glucuronosyltransferases by tertiary amine drugs--implications for adverse drug reactions

21 January 2018

1 reference

Metabolic changes during treatment with valproate in humans: implication for untoward weight gain.

21 January 2018

1 reference

Influence of sodium valproate on late follicular phase pulsatile LH secretion in normal women

21 January 2018

1 reference

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.

21 January 2018

1 reference

Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19096

1 reference

29 July 2017

1 reference